This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

LPRI-CF113 Endometriosis

  • Research type

    Research Study

  • Full title

    A multicentre, phase III, double-blind, randomised clinical trial to assess the efficacy and safety of LPRI-CF113 in the treatment of Endometriosis versus placebo after 3 medication cycles followed by 3 open-label medication cycles



  • Contact name

    Enrico Colli

  • Contact email

  • Sponsor organisation

    Chemo Research S. L.

  • Eudract number


  • Research summary

    The study is aiming to test whether LPRI-CF113 can help in Endometriosis patients within 6 cycles

  • REC name

    East of England - Cambridge South Research Ethics Committee

  • REC reference


  • Date of REC Opinion

    12 Oct 2022

  • REC opinion

    Further Information Favourable Opinion

Shape the future of the HRA website.